Galvus®
El presente sitio está dirigido a médicos con matrícula habilitante dentro de la Región de Centro América y el Caribe, Perú y Ecuador, que acceden a la información de Vildagliptina a través del scan del código QR impreso en el material y/o link proporcionado. Por favor seleccione el país respectivo para su consulta:
This site is directed to doctors with qualifying registration within the Central America and the Caribbean, Peru and Ecuador Region who access information of Vildagliptin through the scan of the QR code printed on the material and/or link provided. Please select the respective country for your inquiry:
The information on this website is provided by Novartis and was approved by the regulatory authority of Aruba. The information contained in the following material is intended solely for Healthcare Professionals authorized to prescribe in these territories and is non-promotional in nature (hereinafter the "Information").
By clicking I confirm that I am a healthcare professional with a clinical practice in Aruba and I am responsible for accessing the prescribing information applicable to Aruba.
The information on this website is provided by Novartis and was approved by the regulatory authority of Bahamas. The information contained in the following material is intended solely for Healthcare Professionals authorized to prescribe in these territories and is non-promotional in nature (hereinafter the "Information").
By clicking I confirm that I am a healthcare professional with a clinical practice in Bahamas and I am responsible for accessing the prescribing information applicable to Bahamas.
The information on this website is provided by Novartis and was approved by the regulatory authority of Barbados. The information contained in the following material is intended solely for Healthcare Professionals authorized to prescribe in these territories and is non-promotional in nature (hereinafter the "Information").
By clicking I confirm that I am a healthcare professional with a clinical practice in Barbados and I am responsible for accessing the prescribing information applicable to Barbados.
The information on this website is provided by Novartis and was approved by the regulatory authority of Curaçao. The information contained in the following material is intended solely for Healthcare Professionals authorized to prescribe in these territories and is non-promotional in nature (hereinafter the "Information").
By clicking I confirm that I am a healthcare professional with a clinical practice in Curaçao and I am responsible for accessing the prescribing information applicable to Curaçao.
The information on this website is provided by Novartis and was approved by the regulatory authority of Guyana. The information contained in the following material is intended solely for Healthcare Professionals authorized to prescribe in these territories and is non-promotional in nature (hereinafter the "Information").
By clicking I confirm that I am a healthcare professional with a clinical practice in Guyana and I am responsible for accessing the prescribing information applicable to Guyana.
The information on this website is provided by Novartis and was approved by the regulatory authority of Jamaica. The information contained in the following material is intended solely for Healthcare Professionals authorized to prescribe in these territories and is non-promotional in nature (hereinafter the "Information").
By clicking I confirm that I am a healthcare professional with a clinical practice in Jamaica and I am responsible for accessing the prescribing information applicable to Jamaica.
La información en este sitio web es proporcionada por Novartis y fue aprobada por la autoridad regulatoria de Nicaragua. La información contenida en el siguiente material está dirigido exclusivamente a Profesionales de la salud autorizados para prescribir en estos territorios y es de naturaleza no promocional (en adelante la “Información”).
The information on this website is provided by Novartis and was approved by the regulatory authority of Trinidad and Tobago. The information contained in the following material is intended solely for Healthcare Professionals authorized to prescribe in these territories and is non-promotional in nature (hereinafter the "Information").
By clicking I confirm that I am a healthcare professional with a clinical practice in Trinidad and Tobago and I am responsible for accessing the prescribing information applicable to Trinidad and Tobago.
La información en este sitio web es proporcionada por Novartis y fue aprobada por la autoridad regulatoria de Uruguay. La información contenida en el siguiente material está dirigido exclusivamente a Profesionales de la salud autorizados para prescribir en estos territorios y es de naturaleza no promocional (en adelante la “Información”).
Para uso exclusivo del profesional médico. Material de uso exclusivo para el profesional de salud. Dirigido a Profesionales de la salud autorizados para prescribir.
La información en esta página web es propiedad de Novartis, o Novartis tiene el derecho de utilizar la misma, por lo cual los profesionales médicos deberán únicamente utilizarla para el ejercicio de su práctica profesional con pacientes, y no deberán replicar o divulgar la misma para fines comerciales o personales. Novartis no se hace responsable por el uso incorrecto de la información por parte de los profesionales médicos o terceros; no obstante, Novartis podrá iniciar las acciones legales que correspondan en estos casos.
Para mayor información favor dirigirse al área de Información Médica de Novartis: Centroamérica, Caribe, Paraguay, Uruguay, West Indies, Perú, Ecuador y Venezuela: [email protected] Chile: [email protected]
